Geneva, 23 April 2021 – Today we welcome the one-year Anniversary of ACT Accelerator (ACT-A) – an unprecedented global partnership established to defeat a global health crisis. The force of ACT-A has been its flexible, solution-oriented and collaborative approach, with all players – governments, business, civil society, and global health organizations – having a seat...
Read moreOn the 1st anniversary of ACT-Accelerator, COVID-19 vaccine makers representing biotechnology firms, developing and developed country manufacturers renew their commitment to produce sufficient vaccines to meet world needs. Increased production output of COVID-19 vaccines is forecast and can be attributed to over 200 manufacturing deals coming online and greater efficiency of a complex process, however,...
Read moreThe press briefing will take stock of the contribution and difficulties of scaling up COVID-19 vaccines production, and the short and longer term challenges that need to be addressed.
Read more
On April 12 and 13 the African Union and the African CDC organized Africa’s Vaccine Manufacturing for Health Security virtual conference, opened by HE Moussa Faki Mahamat, Chairperson of the African Union Commission and chaired by HE Félix Antoine Tshilombo Tshisekedi, Chair of the African Union and President of the Democratic Republic of Congo. Over...
Read moreOn 14 April 2021, IFPMA and a number of its member company experts attended the WTO event “COVID-19 and Vaccine Equity: What can the WTO Contribute”. The meeting was an opportunity to contribute to the WTO Director General, Ngozi Okonjo-Iweala, expressed desire to find pragmatic outcomes to increase COVID-19 vaccine production. IFPMA and its member...
Read moreI am honored to have been invited to speak on behalf of the innovative pharmaceutical industry at the launch of the new Global Diabetes Compact on 14 April 2021. The Global Diabetes Compact is being launched at an important time in history of diabetes. 100 years ago, the discovery of insulin in 1921 kicked off...
Read moreOn 9 April 2021, I participated in very lively debate hosted by Intelligence Squared, and moderated by John Donvan, Putlizer Prize Finalist and America’s best recognized moderator of live event debate and four-time Emmy Award winner. I agreed to disagree with Brook Baker, Professor of Law, Northeastern University School of Law on the future of...
Read moreSpeech Thomas Cueni, Director General, IFPMA 13 April 2021 Good morning. “I have three main messages for you today: First, we hear you, and we are sensitive to the debate about cost and pricing. Second, we are seeing great transformative new treatments reaching patients, and we are making progress through new partnerships in reaching many...
Read moreGeneva, 9 April 2021 – We commend COVAX on the launch of its Web Portal for the no-fault compensation program (NFC) for the 92 low- and middle-income countries eligible for support under the COVAX Advance Market Commitment (AMC). The development of this international NFC system is a historic achievement, and the program will play a...
Read more30 March 2021 – In view of the social and economic impact of current COVID-19 crisis, political leadership in preparing for any eventual future pandemic is crucial. Over the last 12 months we have seen the importance of a strong innovation system and the successful development of several safe and highly effective vaccines in record...
Read more